Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
4/23/26 16:16 | 4/21/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Yoshiyama Annie | CA | O | SVP,Fina | 3 | S.d | -43 | 1.83 | 0 | -23 | 131 | D | |||||||||||||||
4/2/26 16:47 | 3/31/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Beneski Benjamin Machinas | CA | O | SVP,Chie | 6 | S.d | -63 | 2.18 | 0 | -29 | 219 | D | |||||||||||||||
3/18/26 16:05 | 3/16/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Chang David D | CA | DO | P,CEO | 3 | S.d | -381 | 2.01 | 0 | -190 | 8,190 | D | |||||||||||||||
2/4/26 17:16 | 2/2/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Parker Geoffrey M. | CA | O | CFO | 2 | S.d | -88 | 1.46 | 0 | -61 | 1,277 | D | |||||||||||||||
2/4/26 17:12 | 2/2/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Douglas Earl Martin | CA | O | SVP,GC | 1 | S.d | -40 | 1.76 | 0 | -23 | 565 | D | |||||||||||||||
2/4/26 17:07 | 1/21/26 | ALLO | Health | BioPrd | Biological Products, (No Diag | Roberts Zachary | CA | O | EVP of R | 2 | S.d | -104 | 1.68 | 0 | -62 | 617 | D | |||||||||||||||
6/12/25 16:18 | 6/10/25 | ALLO | Health | BioPrd | Biological Products, (No Diag | Messemer Deborah M. | CA | D | 1 | S | -52 | 1.42 | 0 | -37 | 107 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |